Updated October 20, 2026

CFO rankings / Firm profile

Magnano Advisory

Gilbert, AZ · Founded Not disclosed · Last verified 2026-10-07

75
/ 100

Moderate evidence confidence

Scott Magnano working with founder-led companies on fractional CFO retainers, a turnaround, or a sale.

Solo Practitioner, High-TouchTechnology startups, generalBusiness servicesFounder-led / bootstrapped SMB
Magnano Advisory website homepage
Captured October 7, 2026. Visit site

Firm details

HQs
Gilbert, AZ

Headquartered in Gilbert, Arizona, and working nationally.

Typical buyer
Founder-led and PE-backed companies in healthcare, technology, insurance, services, and pharmacy benefit management, including turnaround and exit work.
Specialties
Acting CFO, fractional retainers, and a 30-day Pulse Check. Scott Magnano is the named CFO.

People

Best fit

  • Founders who want Scott Magnano in the CFO seat, including a sale or a turnaround.
  • Buyers who can use a published retainer from $6,000 a month.
  • Companies that can work with a Gilbert-based CFO remotely or in the Phoenix metro.

Poor fit

  • Buyers who want a multi-person finance department staffed by the firm.

Pricing

Published rates, firm estimates, and third-party estimates stay in separate rows.

  • Mobilization fees sit on top of the published retainers, and Acting CFO is custom-scoped
Published rate

Monthly retainer

$6,000-$28,000/mo

Foundations $6,000, Growth $12,000, Keystone $20,000, Acting CFO $28,000. Foundations through Keystone carry a separate mobilization fee.

Retainers page, accessed 2026-10-07.

Retainers
Published rate

Pulse Check

$5,000

30-day diagnostic. Credits toward a retainer if the engagement starts within 60 days.

Retainers page, accessed 2026-10-07.

Retainers

Clients

Named clients and case studies. Each row names its source.

ClientIndustryWhat they didSource
Medicx HealthHealthcare marketingScott Magnano joined as CFO in September 2019. OptimizeRx agreed in October 2023 to acquire Medicx Health for $95 million. His track-record page puts revenue at about $15 million to $40 million and EBITDA margins above 20% during those years. The operating figures are company-reported.Medicx hires Scott Magnano as CFOOptimizeRx agreement to acquire Medicx HealthTrack record

Where Magnano Advisory ranks

Rank is page-relative. See the methodology.

Evidence notes

  • The $15 million to $40 million revenue path and the 20%+ EBITDA margin are his account
  • Score 75 from ratings of 4, 3, 4, 4, and 4 on Track Record, Segment Fit, Pricing Transparency, Responsiveness, and Credentials. Points equal each weight times the rating divided by 5.
  • OptimizeRx's October 12, 2023 release states a $95 million purchase price for Medicx Health. Medicx's September 3, 2019 announcement names Scott Magnano as the new CFO. The $15 million to $40 million revenue path and the 20%+ EBITDA margin are his account.
Main limitation: The sale price is in OptimizeRx's release. The operating results during his CFO years are his account.